Do pediatric headaches respond to bilateral lower cervical paraspinous bupivacaine injections?

Pediatric Emergency Care

Volumn 26, Issue 3, 2010, Pages 192-196

  Mellick, Larry B ^a   Pleasant, Michelle R ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Physicians Regional Medical Center Florida   (United States)

Author keywords

Bupivacaine; Cervical; Headache; Injections; Intramuscular; Migraine

Indexed keywords

BUPIVACAINE;

ADOLESCENT; ANALGESIA; ANESTHESIA INDUCTION; ANESTHESIA MECHANISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEADACHE; HUMAN; MALE; MEDICAL RECORD REVIEW; PAIN ASSESSMENT; REVIEW; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ANESTHETICS, LOCAL; BUPIVACAINE; CERVICAL VERTEBRAE; CHILD; EMERGENCY SERVICE, HOSPITAL; FEMALE; GEORGIA; HEADACHE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77949355134     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3181d1e162     Document Type: Review

References (47)

1. Forsyth R, Farrell K. Headache in childhood. Pediatr Rev. 1999;20:39-45.
2. Bille B. Migraine in school children. Acta Paediatr Scand. 1962;51(suppl 136):1-151.
3. Lewis DW, Gozzo YF, Avner MT. The Bother primary headaches in children and adolescents. Pediatr Neurol. 2005;33(5):303-313.
4. Zwart JA, Dyb G, Holmen TL, et al. The prevalence of migraine and tension-type headaches among adolescents in Norway. The Nord-Trondelag Health Study (Head-HUNT-Youth), a large population-based epidemiological study. Cephalgia. 2004;24(5):373-379.
5. Lipton RB. Diagnosis and epidemiology of pediatric migraine. Curr Opin Neurol. 1997;10(3):231-236.
6. Conicella E, Raucci U, Vanacore N, et al. The child with headache in a pediatric emergency department. Headache. 2008;48(7):1005-1011.
7. Burton LJ, Quinn B, Pratt-Cheney JL, et al. Headache etiology in a pediatric emergency department. Pediatr Emerg Care. 1997;13(1):1-4.
8. Lewis DW, Qureshi F. Acute headache in children and adolescents presenting to the emergency department. Headache. 2000;40(3):200-203.
9. Richer L, Graham L, Klassen T, et al. Emergency department management of acute migraine in children in Canada: a practice variation study. Headache. 2007;47(5):703-710.
10. Mellick GA, Mellick LB. Lower cervical injections for headache relief [letter]. Headache. 2001;41(10):992-994.
11. Mellick GA, Mellick LB. Regional head and face pain relief following lower cervical intramuscular anesthetic injection. Headache. 2003;43:1111-1113.
12. Mellick LB, Mellick GA. Treatment of primary headache in the emergency department [letter]. Headache. 2004;44(8):840-841.
13. Mellick LB, McIlrath ST, Mellick GA. Treatment of headaches in the ED with lower cervical intramuscular bupivacaine injections: a 1-year retrospective review of 417 patients. Headache. 2006;46(9):1441-1449.
14. Mellick LB, Mellick GA. Treatment of acute orofacial pain with lower cervical intramuscular bupivacaine injections: a 1-year retrospective review of 114 patients. J Orofac Pain. 2008 Winter; 22(1):57-64.
15. Malick A, Burstein R. Peripheral and central sensitization during migraine. Funct Neurol. 2000;15(suppl 3):28-35. Review.
16. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47(5):614-624.
17. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123(pt 8):1703-1709.
18. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol. 2004;55(1):27-36.
19. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol. 2004;55(1):19-26.
20. Cady RK, Sheftell F, Lipton RB, et al. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther. 2000;22:1035-1048.
21. Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr Emerg Care. 2008;24(5):321-330.
22. Hoskin KL, Kaube H, Goadsby PJ. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain. 1996;119(pt 5):1419-1428.
23. Kaube H, Hoskin KL, Goadsby PJ. Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache. 1993;33(10):541-544.
24. Hoskin KL, Kaube H, Goadsby PJ. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain. 1996;119(pt 1):249-256.
25. Kaube H, Katsarava Z, Przywara S, et al. Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus? Neurology. 2002;58(8):1234-1238.
26. Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: current concepts and synthesis. Curr Pain Headache Rep. 2003;7:371-376.
27. Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep. 2003;7:377-383.
28. Abrahams VC, Anstee G, Richmond FJ, et al. Neck muscle and trigeminal input to the upper cervical cord and lower medulla of the cat. Can J Physiol Pharmacol. 1979;57:642-651.
29. Piovesan EJ, Kowacs PA, Tatsui CE, et al. Referred pain after painful stimulation of the greater occipital nerve in humans: evidence of convergence of cervical afferences on trigeminal nuclei. Cephalalgia. 2001;21:107-109.
30. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain. 2002;125:1496-1509.
31. Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain. 2003;126:1801-1813.
32. Ambrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005;118:92-96.
33. Mason P. Deconstructing endogenous pain modulations. J Neurophysiol. 2005;94(3):1659-1663. Review.
34. Ashkenazi A, Silberstein SD. Headache management for the pain specialist. Reg Anesth Pain Med. 2004;29(5):462-475. Review.
35. Peres MFP, Stiles MA, Siow HC, et al. Greater occipital nerve blockade for cluster headache. Cephalalgia. 2002;22:520-522.
36. Bogduk N, Marsland A. On the concept of third occipital headache. J Neurol Neurosurg Psychiatry. 1986;49(7):775-780.
37. Lord SM, Barnsley L, Wallis BJ, et al. Third occipital nerve headache: a prevalence study. J Neurol Neurosurg Psychiatry. 1994;57(10):1187-1190.
38. Aprill C, Axinn MJ, Bogduk N. Occipital headaches stemming from the lateral atlanto-axial (C1-2) joint. Cephalalgia. 2002;22(1):15-22.
39. Anthony M. Cervicogenic headache: prevalence and response to local steroid therapy. Clin Exp Rheumatol. 2000;8(2 suppl 19):S59-S64.
40. Albertyn J, Barry R, Odendaal CL. Cluster headache and the sympathetic nerve. Headache. 2004;44(2):183-185.
41. Brofeldt BT, Panacek EA. Pericranial injection of local anesthetics for the management of resistant headaches. Acad Emerg Med. 1998;5:1224-1229.
42. Hecht JS. Occipital nerve blocks in postconcussive headaches: a retrospective review and report of ten patients. J Head Trauma Rehabil. 2004;19(1):58-71.
43. Caputi CA,Vincenzo F. Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients. Headache. 1997;37:174-179.
44. Ashkenazi A, Young W. The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine. Headache. 2005;45:350-354.
45. Jones J, Sklar D, Dougherty J, et al. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA. 1989;261:1174-1176.
46. Ginder S, Oatman B, Pollack M. A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches. J Emerg Med. 2000;18:311-315.
47. Damen L, Bruijn JK, Verhagen AP, et al. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics. 2005;116(2):e295-e302.